Skip to content
Evigrade
CriticalSSRI (selective serotonin reuptake inhibitor)×Serotonin antagonist and reuptake inhibitor (SARI) antidepressant

Updated · Methodology

Mechanism

Citalopram prolongs the QT interval in a dose-dependent way. In healthy volunteers, the heart rate-corrected QT interval rose by 7.5 ms at 20 mg a day and by 16.7 ms at 60 mg a day (citalopram summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; citalopram label, US Food and Drug Administration, FDA). Trazodone also prolongs the QT interval, and its adverse reactions include torsade de pointes (trazodone FDA label and AEMPS SmPC). No study has tested this pair, but the documents of both drugs warn that the effects on QT may add up (citalopram SmPC, AEMPS; trazodone FDA label). Both drugs increase serotonin activity. The trazodone SmPC describes serotonin syndrome in people who took trazodone with selective serotonin reuptake inhibitors (SSRIs), the group citalopram belongs to (AEMPS). The liver forms the active metabolite of trazodone mainly through the enzyme CYP3A4, and citalopram has a negligible effect on this enzyme (trazodone and citalopram SmPCs, AEMPS).

Symptoms

QT interval prolongation itself causes no symptoms and shows only on the electrocardiogram (ECG). Torsade de pointes, a ventricular tachycardia, causes palpitations, dizziness and fainting. With citalopram, such arrhythmias were reported mainly in women and in people with low potassium, a pre-existing long QT interval or other heart disease (citalopram summary of product characteristics, SmPC). Serotonin syndrome presents with agitation, tremor, muscle jerks and fever (citalopram SmPC). Hallucinations, a fast pulse, unstable blood pressure, sweating, nausea, vomiting and diarrhoea may also occur (labels of both drugs, US Food and Drug Administration, FDA). Trazodone causes somnolence and a drop in blood pressure on standing, sometimes with fainting, more often in older people (trazodone SmPC).

Management

The combination is contraindicated because citalopram must not be given to people taking drugs that prolong the QT interval (citalopram summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Trazodone prolongs QT according to its own documents (trazodone label, US Food and Drug Administration, FDA, and SmPC, AEMPS). The FDA labels of both drugs say to avoid this combination (citalopram and trazodone FDA labels). The UK National Institute for Health and Care Excellence (NICE) lists adding trazodone to a selective serotonin reuptake inhibitor (SSRI) as an option when depression has had no response or a limited response to an antidepressant. NICE also advises considering referral to a specialist mental health service or consulting a specialist, and explaining to the patient in advance that side effects may increase (NICE NG222). If the patient still takes both drugs, correct low potassium and magnesium before starting citalopram (citalopram SmPC, AEMPS). If signs of arrhythmia appear, stop citalopram and record an electrocardiogram (citalopram SmPC, AEMPS). With other QT-prolonging drugs, the citalopram FDA label recommends electrocardiogram monitoring and stopping citalopram if the corrected QT interval (QTc) stays above 500 ms. In people at risk of electrolyte disturbances, it also recommends measuring potassium and magnesium at baseline and periodically (citalopram FDA label). The daily citalopram dose is at most 40 mg, and at most 20 mg in people over 65, in mild or moderate liver impairment and in CYP2C19 poor metabolizers (citalopram SmPC, AEMPS). Avoid trazodone in people with a history of arrhythmias, symptomatic bradycardia or congenital QT prolongation (trazodone FDA label). Somnolence and orthostatic hypotension from trazodone can add to the effects of other psychotropic drugs, especially in older people. Warn the patient or carer and watch these effects closely after the start and before and after each dose increase (trazodone SmPC, AEMPS). Monitor for serotonin syndrome, particularly at the start of citalopram and after dose increases (citalopram FDA label). If it appears, stop both drugs at once and start symptomatic treatment (citalopram and trazodone SmPCs, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Citalopram

Other interactions with Trazodone